Work

Ganglionic Antibody Level as a Predictor of Severity of Autonomic Failure

Year: 2018

Type: article

Study design: Observational Study

Source: Mayo Clinic Proceedings

DOI: 10.1016/j.mayocp.2018.05.033

Authors: Jeremy K. Cutsforth-Gregory, Andrew McKeon, Elizabeth A. Coon, David M. Sletten, Mariana Suarez, Paola Sandroni, Wolfgang Singer, Eduardo E. Benarroch, Robert D. Fealey, Phillip A. Low

Institution: Mayo Clinic

Language: English

Topic: Myasthenia Gravis and Thymoma

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, U.S. Food and Drug Administration, Food and Drug Administration, National Institute of Neurological Disorders and Stroke, National Center for Advancing Translational Sciences

Awards: Pathogenesis and Diagnosis of Multiple System Atrophy (P01), Mayo Clinic Center for Clinical and Translational Science (CCaTS), G3308772956, G3872400531, Autonomic Rare Diseases Clinical Research Consortium, Differential Approach to the Postural Tachycardia Syndrome, Mayo Clinic Center for Clinical and Translational Science (CCaTS), Synucleinopathies – Novel Targets in Early Diagnosis, Pathophysiology, and Therapeutic Approach

OpenAlex ID: W2888959630

FWCI: 2.163

Cites: 38

Cited by: 28

Related to: 10